key: cord-0812433-cw2wnvy4 authors: Yamaji, Kazunori; Mitsutake, Yoshiaki; Nakano, Masaharu; Nakamura, Takuya; Fukumoto, Yoshihiro title: Robotic-assisted percutaneous coronary intervention in the COVID-19 pandemic date: 2021-08-19 journal: J Cardiol DOI: 10.1016/j.jjcc.2021.08.006 sha: c6d0da49f5068e3e2a95efeed277394a9234ce68 doc_id: 812433 cord_uid: cw2wnvy4 Coronavirus disease-2019 (COVID-19) has a profound impact on the health care system worldwide. In the COVID-19 pandemic, hospitals are required to halt elective surgeries and procedures for preventing nosocomial infections and saving medical resources. In these situations, emergency procedures are required for life-threatening cardiovascular diseases such as acute coronary syndrome and cardiogenic shock. To prevent the spread of COVID-19, a social distance is essentially required. In ordinary percutaneous coronary intervention (PCI), operators manipulate the devices standing at the patient's tableside during the whole procedure, which may involve a certain risk of exposure to patients with COVID-19. A robotic-assisted PCI (R-PCI) allows operators to manipulate devices remotely, sitting at a cockpit located several meters away from the patient, and in addition, the assistant can be at the foot of the bed, much further from the access site. R-PCI can help to minimize the radiation exposure and the amount of person-to-person contact, and consequently may reduce the risk for the exposure to the virus. The coronavirus disease-2019 (COVID- 19) COVID-19 continues to have a profound impact on the health care system worldwide. In Japan, more than 800,000 people have been infected and over 15,000 people have infections have occurred to date. Therefore, the development of a system for infection prevention is very important in hospitals. Clinical care of patients with COVID-19 overwhelms the medical resources such as personal protective equipment (PPE) supplies, ventilators, or extracorporeal membrane oxygenation, leading to occupy medical staff, medical floors, and intensive care units. For preventing nosocomial infections and saving medical resources, elective surgeries and procedures have been halted. In these situations, emergency procedures are required for life-threatening cardiovascular diseases such as acute coronary syndrome (ACS) and cardiogenic shock. In this review article, we summarize the efficacy of robotic-assisted percutaneous coronary intervention (R-PCI) which has a potential to minimize interpersonal contact in the COVID-19 pandemic. The transmission routes of SARS-CoV-2 are direct contact, respiratory droplets secreted from infected individuals, and aerosol transmissions [3] [4] [5] . In general, infected people spread virus particles by talking, breathing, coughing, and sneezing. The large droplets secreted from patient's mouth quickly fall to the ground, but smaller aerosols drift in the air for a while and can spread 1-2 meters from patients [6, 7] . Although the median estimates of half-life are approximately 1.1-1.2 hours, SARS-CoV-2 can survive in aerosols longer than 3 hours, which indicates that the virus has stability characteristics in transmitting through the air [8, 9] . Furthermore, the virus is stable to exist on the surfaces of some objects for a while, particularly on stainless steel and plastic surfaces, where it can remain active up to 72 hours [9] . Aerosols are created in common clinical settings. The US Centers for Disease Control and Prevention (CDC) defines "aerosolgenerating procedures (AGPs)" as procedures that create uncontrolled respiratory secretions or procedures with the potential to generate infectious respiratory particles at higher concentrations than breathing, coughing, sneezing, or talking [10] . AGPs contain sputum induction, noninvasive positive pressure ventilation, intubation, and cardiopulmonary resuscitation (CPR). During these procedures, we need to prevent the infection much more strictly [11] . Generally, it is essential for the prevention of COVID-19 to keep a social distance, to wear a facemask, to wash hands frequently, and to ventilate a room regularly [1, 7, 8]. Healthcare providers, particularly medical staff who perform AGPs, have higher risks of exposure from patients or infectious materials including body substances (e.g. blood, tissue, and specific body fluids), contaminated medical equipment, environmental surface, or air [12] . In clinical settings, appropriate PPE should be worn such as facemasks, gown, eye shield, and gloves. When caring for patients with COVID-19, we should wear N95 respirators or masks, equivalent or better [12] . N95 respirators cannot block completely the transmission of viral droplets and aerosols, even if completely sealed [13] , but can halve the risk of respiratory infections compared to surgical masks [14] . In closed space such as a catheterization laboratory, it is difficult to keep enough distance from a patient. During procedures, operators are required to stand by the patient table for several hours. Furthermore, if the patient's condition gets worse, AGPs such as suctioning, intubation, or CPR may be required. Catheterization laboratories are usually positive-pressure ventilated to prevent circulation of pathogens, which would not be an ideal strategy for preventing infection from COVID-19 [15, 16] . Therefore, COVID-19 or suspected COVID-19 patients with poor respiratory status should be intubated prior to arrival at the catheterization laboratory, and also a patient with borderline respiratory status should be considered for intubation. In general, catheterization laboratories are designed as Level III clean areas and it requires approximately one hour of ventilation to remove airborne aerosols sufficiently [16] . The R-PCI system, the CorPath ® GRX system (Corindus, Waltham, MA, USA), has been developed to reduce the radiation exposure to the operator and the physical burden from the heavy radiation protective equipment. R-PCI allows operators to manipulate PCI devices remotely sitting at a cockpit located several meters away from the patient, and in addition, the assistant can be at the foot of the bed much further from the access site. The details of the CorPath GRX system were described elsewhere [25, 26] . Briefly, the CorPath GRX system consists of an interventional cockpit and a bedside unit (Fig. 1) . The interventional cockpit is a radiation-shielded mobile workstation that contains a console with joysticks and touchscreen controls to move the balloon/stent delivery system, guidewire, or guiding catheter. The bedside unit is composed of a single-use cassette, articulating arm, and robotic drive. During the PCI procedure, the single-use cassette is mounted on a robotic drive and loaded with interventional equipment, which translates commands from the cockpit to independently manipulate each device In conventional PCI, operators manipulate the devices standing at the patients' tableside during the whole procedure. Therefore, conventional PCI style may involve a certain risk of exposure to patients with COVID-19. Regarding this matter, R-PCI may have a potential to reduce the risk [27, 28]. In R-PCI with the present CorPath system, someone needs to be close to the table for preparation of the patient and exchange the PCI devices in the cassette. However, except those timings, all catheterization laboratory staff can stay away from the tableside. In a pandemic situation such as COVID-19, R-PCI may help to minimize the amount of person-to-person contact [29] . A 50-year-old woman with medical history of type 1 diabetes mellitus and end-stage renal disease on hemodialysis, was transferred to our hospital with a state of acute respiratory failure and vital shock. The patient was intubated for mechanical ventilation and administered catecholamines to increase the blood pressure. She had a fever and a high level of inflammatory reaction in the blood test, white blood cells: 20,500 /μL and C-reactive protein: 13.0 mg/dL. A chest X-ray and a computed tomography scan revealed bilateral pneumoniae and bilateral pleural effusions (Fig. 2 ). An antigen test and a polymerase chain reaction test for COVID-19 were performed. A 12-lead electrocardiogram showed ST elevation in V3-6 leads and abnormal Q wave in Ⅰ, Ⅱ, Ⅲ , aVF, and V3-6 leads (Fig. 3) . The blood test revealed the elevated levels of creatine kinase MB (CK-MB) and cardiac troponin T (TnT), CK-MB: 69 U/L and TnT: 29.4 ng/ml. The patient was diagnosed as having STEMI, cardiogenic shock, and suspected concurrent COVID-19 infection. In consideration with the patient's condition, an urgent revascularization therapy with full PPE was performed. In addition, in order to keep the distance between the patient and the catheterization laboratory staff, R-PCI was chosen. All staff inside the operating room wore full PPE; N95 masks or powered air purifying respirator systems (CleanSpace Ⓡ HALO, CleanSpace Technology Pty Ltd., Artarmon, Australia), face shields, gowns, double gloves, and socks. The patient was on a ventilator with high-efficiency particulate air filter. Arterial access was secured manually to the left femoral artery. After administration of appropriate anticoagulation and antiplatelet agents, coronary angiography (CAG) was performed manually. CAG revealed severe stenosis with thrombus in the left anterior descending artery (LAD), thrombotic obstruction in the left circumflex artery (LCx), and severe stenosis in the right coronary artery (Fig. 4) . Both the lesions at the LAD and the LCx were judged as culprit lesions and we started R-PCI under support of intra-aortic balloon pumping (IABP). The operator was stationed in a cockpit 4 meters away from the patient, and the assistants at the tableside kept their distance from the patient as much as possible (Fig. 5) . After manual engagement of a 6 Fr. guiding catheter in the left coronary artery, a 0.014-inch SION Blue guidewire (Asahi Intecc., Aichi, Japan) was robotically advanced into the distal LCx. Then, a 2.5 mm semi-compliant Traveler balloon catheter (Abbott Vascular, Santa Clara, CA, USA) was inserted into the lesion robotically. Following dilatation with the balloon, optical coherence tomography (OCT) was performed manually by the assistants. OCT revealed diffuse atherosclerotic stenosis in the LCx. Three XIENCE stents (Abbott Vascular) were placed robotically and deployed to fully cover the lesion. Regarding the LAD lesion, the insertion of the guidewire and the delivery of the balloon and the stent catheter were performed by the R-PCI system. A XIENCE stent was implanted at the LAD lesion. Final CAG showed excellent results at both the LAD and the LCx without any complications (Fig. 4) . The patient was found negative for the COVID-19 PCR test on the following day. On day 3, IABP was withdrawn and staged PCI for the RCA stenotic lesion was performed manually and succeeded. Mechanical respiratory support was withdrawn on day 32. R-PCI in STEMI patents is challenging. There has been limited information on clinical performance of R-PCI in STEMI patients, because previous R-PCI studies excluded those patients [30] . It has been demonstrated that procedural time was about 10 minutes longer in R-PCI than that in manual PCI in stable patients [31, 32] , which could be caused by more time in robotic drive setup and loading the robotic drive with PCI devices. Therefore, there is a concern that R-PCI in STEMI patients would prolong door-to-balloon time. Regarding this issue, more training and experience may ameliorate this problem. R-PCI with the CorPath system allows all staff to be away from the patient bedside for most of the time during the procedure, thus minimizing the proximity to the patient. In special situations, such as the COVID-19 pandemic, lowering the infection risk of medical staff might be prioritized over slight prolongation of procedure time. As reports of R-PCI in patients with COVID-19 or STEMI are still scarce, further studies are warranted to evaluate the utility, particularly in pandemic environments. Improvements in the R-PCI system and AI technology may enable us to handle more difficult cases, reduce human errors, and remote R-PCI. Current R-PCI have automated wiring aid technique called Rotate on Retract (RoR) and additional automated features will be provided to assist with complex tasks such as crossing lesions, navigating tortuosity, and precisely measuring the anatomy for appropriate device size selection in the future [33] . Remote R-PCI has already been actualized (blue arrow) , and the assistants also maintained a sufficient distance from the patient. World Health Organization. Coronavirus disease (COVID-19) pandemic Available at An updated understanding of the current emerging respiratory infection: COVID-19 Transmission routes for SARS-CoV-2 infection: review of evidence Basic virology, epidemiology, cardiac manifestations, and potential therapeutic strategies Centers for Disease Control and Prevention. How COVID-19 Spreads Evaporation and dispersion of respiratory droplets from coughing Transmission of COVID-19 virus by droplets and aerosols: A critical review on the unresolved dichotomy Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1 Clinical questions about COVID-19: Questions and answers Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review Interim infection prevention and control recommendations for healthcare personnel during the coronavirus disease Effectiveness of face masks in preventing airborne transmission of SARS-CoV-2 The need of health policy perspective to protect healthcare workers during COVID-19 pandemic. A GRADE rapid review on the N95 respirators effectiveness Catheterization laboratory considerations during the coronavirus (COVID-19) pandemic: From the ACC's Interventional Council and SCAI The Japanese Association of Cardiovascular Intervention and Therapeutics position statement on coronary invasive procedures during the COVID-19 pandemic in Japan the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP) Impact of coronavirus disease 2019 (COVID-19) outbreak on ST-segment-elevation myocardial infarction care in Hong Kong How to balance acute myocardial infarction and COVID-19: the protocols from Sichuan Provincial People's Hospital A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the American College of Emergency Physicians and Society for Cardiovascular Angiography and Interventions Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial First experience of robotic-assisted percutaneous coronary intervention in Japan Successful introduction of robotic-assisted percutaneous coronary intervention system into Japanese clinical practice: a first-year survey at single center Concerns for management of STEMI patients in the COVID-19 era: a paradox phenomenon Robotic-assisted percutaneous coronary intervention in a COVID-19 patient Demonstration of the safety and feasibility of robotically assisted percutaneous coronary intervention in complex coronary lesions: Results of the CORA-PCI Study (Complex Robotically Assisted Percutaneous Coronary Intervention) Safety and feasibility of robotic percutaneous coronary intervention: PRECISE (Percutaneous Robotically-Enhanced Coronary Intervention) Study Comparison of robotic percutaneous coronary intervention with traditional percutaneous coronary intervention: a propensity score-matched analysis of a large cohort Corindus announces global launch of technIQ™1 smart procedural automation series for CorPath® GRX System Long distance tele-robotic-assisted percutaneous coronary intervention: A report of first-in-human experience Robotic telestenting performance in transcontinental and regional pre-clinical models The authors gratefully acknowledge the technical assistance of the staff in the cardiac catheterization laboratory of Kurume University Hospital. This article was written with no external sources of funding. There is no conflict of interest to disclose.